This inventor holds 8 USPTO granted patents and 1 EPO patent. Top assignees: Elan Pharmaceuticals, Inc., Eli Lilly and Company, Athena Neurosciences, Inc.. Active years: 1997-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 202 
3 out of 4,514 
2 out of 35 
Years Active: 1997-2010
Title: Carmen Vigo-Pelfrey: Innovator in Alzheimer's Disease Diagnosis
Introduction
Carmen Vigo-Pelfrey is a notable inventor based in Mountain View, CA (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of Alzheimer's disease. With a total of 8 patents to her name, her work has the potential to greatly impact the way Alzheimer's is diagnosed and understood.
Latest Patents
One of her latest patents focuses on methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≥41) and tau. This invention provides methods useful in aiding in the diagnosis of Alzheimer's disease. The methods involve measuring the amount of amyloid-β peptide (x−≥41) in the cerebrospinal fluid of a patient. High levels of the peptide generally are inconsistent with a diagnosis of Alzheimer's. Low levels of the peptide are consistent with the disease and, with other tests, can provide a positive diagnosis. Other methods involve measuring the amounts of both Aβ(x−≥41) and tau. Low levels of Aβ(x−≥41) and high levels of tau are a positive indicator of Alzheimer's disease, while high levels of Aβ(x−≥41) and low levels of tau are a negative indication of Alzheimer's disease.
Career Highlights
Throughout her career, Carmen has worked with prominent companies in the pharmaceutical industry, including Elan Pharmaceuticals, Inc. and Eli Lilly and Company. Her experience in these organizations has allowed her to develop innovative solutions that address critical health issues.
Collaborations
Carmen has collaborated with notable professionals in her field, including Peter A. Seubert and Dale Bernard Schenk. These collaborations have further enriched her research and development efforts.
Conclusion
Carmen Vigo-Pelfrey's contributions to the diagnosis of Alzheimer's disease through her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in understanding and diagnosing this complex disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile